Elevation of asymmetrical dimethylarginine (ADMA) and coronary artery disease in men with erectile dysfunction

European Urology

Volumn 48, Issue 6, 2005, Pages 1004-1012

  Maas, Renke ^a   Wenske, Sven ^a,b   Zabel, Marcus ^a   Ventura, Rodolfo ^a   Schwedhelm, Edzard ^a   Steenpaß, Anna ^a   Klemm, Hanno ^a   Noldus, Joachim ^a,b   Böger, Rainer H ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

ADMA; Asymmetrical dimethylarginine; Coronary artery disease; Erectile dysfunction; Risk factor

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC TEST; DIET RESTRICTION; DISEASE MARKER; ERECTILE DYSFUNCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOGLYCEMIA; INTERNATIONAL INDEX OF ERECTILE FUNCTION SCORE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM;

EID: 27844508262     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.07.017     Document Type: Article

References (30)

1. Anonymous. Impotence. NIH Consens Statement. 1992;10:1-33.
2. J.S. Green, S.T. Holden, P. Ingram, P. Bose, D.P. St George, and W.G. Bowsher An investigation of erectile dysfunction in Gwent, Wales BJU Int 88 2001 551 553
3. I.A. Ayta, J.B. McKinlay, and R.J. Krane The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences BJU Int 84 1999 50 56
4. R. Virag, P. Bouilly, and D. Frydman Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men Lancet 1 8422 1985 181 184
5. C. Gazzaruso, S. Giordanetti, E. De Amici, G. Bertone, C. Falcone, and D. Geroldi Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients Circulation 110 2004 22 26
6. H.A. Feldman, I. Goldstein, D.G. Hatzichristou, R.J. Krane, and J.B. McKinlay Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study J Urol 151 1994 54 61
7. M.E. Sullivan, S.R. Keoghane, and M.A. Miller Vascular risk factors and erectile dysfunction BJU Int 87 2001 838 845
8. M. Wei, C.A. Macera, D.R. Davis, C.A. Hornung, H.R. Nankin, and S.N. Blair Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction Am J Epidem 140 1994 930 937
9. J. Rajfer, W.J. Aronson, P.A. Bush, F.J. Dorey, and L.J. Ignarro Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission N Engl J Med 326 1992 90 94
10. A.L. Burnett Nitric oxide in the penis: physiology and pathology J Urol 157 1997 320 324
11. R. Maas, E. Schwedhelm, J. Albsmeier, and R.H. Böger The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function Vasc Med 7 2002 213 225
12. H. Solomon, J.W. Man, and G. Jackson Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator Heart 89 2003 251 253
13. R. Virag, J. Floresco, and C. Richard Impairment of shear-stress-mediated vasodilation of cavernous arteries in erectile dysfunction Int J Impot Res 16 2004 39 42
14. T.M. Lu, Y.A. Ding, S.J. Lin, W.S. Lee, and H.C. Tai Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention Eur Heart J 24 2003 1912 1919
15. V.P. Valkonen, H. Paiva, J.T. Salonen, T.A. Lakka, T. Lehtimaki, and J. Laakso Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine Lancet 358 2001 2127 2128
16. J.P. Cooke Asymmetrical dimethylarginine: the über marker? Circulation 109 2004 1813 1818
17. M.E. Sullivan, C.S. Thompson, M.R. Dashwood, M.A. Khan, J.Y. Jeremy, and R.J. Morgan Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res 43 1999 658 665
18. T. Roumeguere, E. Wespes, Y. Carpentier, P. Hoffmann, and C.C. Schulman Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk Eur Urol 44 2003 355 359
19. Levine LA Diagnosis and treatment of erectile dysfunction Am J Med 109 9 suppl 1 2000 3 12
20. R.C. Rosen, A. Riley, G. Wagner, I.H. Osterloh, J. Kirkpatrick, and A. Mishra The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction Urology 49 6 1997 822 830
21. R.C. Rosen, J.C. Cappelleri, M.D. Smith, J. Lipsky, and B.M. Pena Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction Int J Impot Res 11 1999 319 326
22. A.I. El-Sakka Association between International Index of Erectile Function and axial penile rigidity in patients with erectile dysfunction Int J Impot Res 15 2003 426 429
23. R.H. Böger, S.M. Bode-Böger, A. Szuba, P.S. Tsao, J.R. Chan, and O. Tangphao Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia Circulation 98 1998 1842 1847
24. K. Sydow, E. Schwedhelm, N. Arakawa, S.M. Bode-Böger, D. Tsikas, and B. Hornig ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins Cardiovasc Res 57 2003 244 252
25. H. Masuda, T. Tsujii, T. Okuno, K. Kihara, M. Goto, and H. Azuma Accumulated endogenous NOS inhibitors, decreased NOS activity, and impaired cavernosal relaxation with ischemia Am J Physiol Regul Integr Comp Physiol 282 2002 1730 1738
26. D. Tsikas, R.H. Böger, J. Sandman, S. Bode-Böger, and J. Frölich Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox FEBS Lett 23810 2000 1 3
27. T.J. Bivalacqua, W.J. Hellstrom, P.J. Kadowitz, and H.C. Champion Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction Biochem Biophys Res Commun 283 2001 923 927
28. J.D. Cox, N.N. Kim, A.M. Traish, and D.W. Christianson Arginase-boronic acid complex highlights a physiological role in erectile function Nat Struct Biol 6 1999 1043 1047
29. J. Chen, Y. Wollman, T. Chernichovsky, A. Laina, M. Sofer, and H. Matzkin Effect of oral administration of high dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double blind, randomized, placebo controlled study BJU Int 83 1999 267 273
30. T. Klotz, M.J. Mahers, M. Braun, W. Bloch, and U. Engelmann Effectiveness of oral L-arginine in first-line treatment of erectile dysfunction in a controlled crossover study Urol Int 63 1999 220 223